ArticlePloS one2022

Construction and evaluation of a self-replicative RNA vaccine against SARS-CoV-2 using yellow fever virus replicon.

Akina Nakamura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.